Featured articles

The Keith Peters Building

On Thursday, 4 April, Professor Sir Keith Peters unveiled a plaque in reception to mark the formal re-naming of the Wellcome Trust/MRC Building as The Keith Peters Building. We share this building with the Cambridge Institute of Medical Research (CIMR). Further information about the renaming event is available via CIMR's website.

Rare disease day: 28 February

28 February is the twelfth international Rare Disease Day, coordinated by EURORDIS.

Around this date, awareness-raising activities are taking place all over the world.

The MBU's contribution was a mitochondrial face-painting event - great fun was had by all!

Professor Patrick Chinnery appointed as MRC Clinical Director

Congratulations to Professor Patrick Chinnery, who has been appointed as the MRC's Clinical Director.

Patrick will play a key role in developing, promoting and implementing MRC research programmes, both nationally and internationally.

Patrick is very excited about the opportunities that this new role presents for the translation of laboratory research into improvements in healthcare.

The full press release can be found on the MRC's news page.

A new drug target for tuberculosis

Professor John Walker and his colleagues have solved the first structure of an F1 domain from a bacterial pathogen family, which could lead to the development of new drugs to prevent and cure tuberculosis (TB) to follow on from the recently developed anti-TB drug Bedaquiline which targets the membrane domain of ATP synthase, and is used for treating multi-drug-resistant TB.

ATP (adenosine triphosphate) is the fuel of life and is generated in cellular organisms by an enzyme called ATP synthase.

Pages